furosemide has been researched along with Mitral Valve Insufficiency in 33 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Mitral Valve Insufficiency: Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.
Excerpt | Relevance | Reference |
---|---|---|
" All dogs entered in the study received standard heart failure treatment (furosemide with or without digoxin)." | 9.08 | Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group. ( Benitz, AM; Cifelli, S; Ericsson, GF; Ettinger, SJ; Hanson, PD; Jernigan, AD; Longhofer, SL; Trimboli, W, 1998) |
"Mean furosemide dose on day 0 was 5." | 6.77 | Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease. ( Machen, MC; Oyama, MA; Peddle, GD; Reynolds, CA; Singletary, GE; Trafny, DJ, 2012) |
"Ibopamine is a novel oral dopamine analogue with positive inotropy and diuretic effects." | 6.67 | [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure]. ( Gerzer, R; Theisen, K; Wehling, M; Weil, J; Zimmermann, J, 1990) |
" All dogs entered in the study received standard heart failure treatment (furosemide with or without digoxin)." | 5.08 | Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group. ( Benitz, AM; Cifelli, S; Ericsson, GF; Ettinger, SJ; Hanson, PD; Jernigan, AD; Longhofer, SL; Trimboli, W, 1998) |
"For study purposes, advanced heart failure was defined as recurrence of congestive heart failure signs despite receiving the initially prescribed dose of pimobendan, angiotensin-converting-enzyme inhibitor (ACEI), and furosemide >4 mg/kg/day." | 3.88 | Clinical findings and survival time in dogs with advanced heart failure. ( Beaumier, A; Freeman, LM; Rush, JE; Yang, VK, 2018) |
"This retrospective study reports the survival time [onset of congestive heart failure (CHF) to death from any cause] of 21 dogs with mitral regurgitation (MR) and CHF treated with a combination of furosemide, angiotensin-converting enzyme inhibitor (ACEI, benazepril, or enalapril), pimobendan, spironolactone, and amlodipine." | 3.77 | Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases. ( de Madron, E; King, JN; Strehlau, G; White, RV, 2011) |
" After treatment of the cardiac failure with frusemide (up to 500 mg daily intravenously), nitrates and captopril (25 mg daily by mouth) the diagnosis was confirmed by transoesophageal echocardiography." | 3.69 | [Acute mitral insufficiency in osteogenesis imperfecta]. ( Borchard, F; Horstkotte, D; Kober, R; Königshausen, T; Krahwinkel, W; Strauer, BE; Winter, J, 1994) |
"Four dogs with congestive heart failure associated with dirofilariasis and mitral valvular incompetence initially responded to treatment with digoxin or etamiphylline camsylate, and frusemide but became refractory to this therapy and were in cardiac decompensation." | 3.66 | The use of alpha blockade in the treatment of congestive heart failure associated with dirofilariasis and mitral valvular incompetence. ( Atwell, RB, 1979) |
"Mean furosemide dose on day 0 was 5." | 2.77 | Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease. ( Machen, MC; Oyama, MA; Peddle, GD; Reynolds, CA; Singletary, GE; Trafny, DJ, 2012) |
"Ibopamine is a novel oral dopamine analogue with positive inotropy and diuretic effects." | 2.67 | [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure]. ( Gerzer, R; Theisen, K; Wehling, M; Weil, J; Zimmermann, J, 1990) |
"While rare, improvement in mitral regurgitation severity may occur without surgical intervention, allowing for reverse left-sided cardiac remodeling and discontinuation of furosemide." | 1.91 | Resolution of congestive heart failure and reverse remodeling in two Chihuahuas with flail mitral valve leaflets. ( Wesselowski, S, 2023) |
"Spironolactone treatment demonstrated significant attenuation of cardiac fibrosis and apoptosis in left ventricular tissue compared to furosemide." | 1.72 | Mineralocorticoid Receptor Antagonists Mitigate Mitral Regurgitation-Induced Myocardial Dysfunction. ( Chang, WT; Chen, CY; Chen, ZC; Lin, YW; Liu, PY; Luo, CY; Shih, JY; Wu, CC, 2022) |
"cardiac death or death for other causes)." | 1.62 | Multiple retrospective analysis of survival and evaluation of cardiac death predictors in a population of dogs affected by degenerative mitral valve disease in ACVIM class C treated with different therapeutic protocols. ( Bagardi, M; Brambilla, PG; Galizzi, A; Locatelli, C; Malchiodi, D; Zanaboni, A, 2021) |
"Progression of tricuspid regurgitation (TR) may occur after mitral valve replacement (MVR)." | 1.46 | Progression of Tricuspid Regurgitation after Mitral Valve Replacement for Rheumatic Heart Disease. ( Q Tri, HH; Vinh, PN, 2017) |
"In humans with congestive heart failure (CHF), better outcome is correlated with lower natriuretic peptide (NP) levels after starting treatment and greater percentage reduction of NP levels." | 1.38 | Lowered N-terminal pro-B-type natriuretic peptide levels in response to treatment predict survival in dogs with symptomatic mitral valve disease. ( Gerlach, N; Klima, A; Weber, K; Wess, G; Wolf, J, 2012) |
"Furosemide was added after the 3-week examination, and at 6 months, dogs had received furosemide for at least 4 months." | 1.29 | Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation. ( Häggström, J; Hansson, K; Karlberg, BE; Kvart, C; Madej, A; Olsson, K, 1996) |
"In advanced heart failure, mitral regurgitation increases the burden of the failing ventricle and decreases effective stroke volume." | 1.28 | Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. ( Belil, D; Brunken, RC; Grover-McKay, M; Schelbert, HR; Schwaiger, M; Stevenson, LW; Tillisch, JH, 1990) |
"Seventeen patients with dilated cardiomyopathy (mean ejection fraction 22%) in the NYHA state III or IV were investigated." | 1.28 | Daily administration of furosemide in dilated cardiomyopathy--yes or no? ( Mihatov, S; Nikolić, VH; Omcikus, MP; Petrać, D; Rudar, M; Vukosavić, D, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (18.18) | 18.7374 |
1990's | 11 (33.33) | 18.2507 |
2000's | 3 (9.09) | 29.6817 |
2010's | 8 (24.24) | 24.3611 |
2020's | 5 (15.15) | 2.80 |
Authors | Studies |
---|---|
Caiati, C | 1 |
Argentiero, A | 1 |
Favale, S | 1 |
Lepera, ME | 1 |
Chang, WT | 1 |
Lin, YW | 1 |
Chen, CY | 1 |
Chen, ZC | 1 |
Shih, JY | 1 |
Wu, CC | 1 |
Luo, CY | 1 |
Liu, PY | 1 |
Wesselowski, S | 1 |
McVeigh, T | 1 |
Moore, C | 1 |
Bagardi, M | 1 |
Locatelli, C | 1 |
Zanaboni, A | 1 |
Galizzi, A | 1 |
Malchiodi, D | 1 |
Brambilla, PG | 1 |
Q Tri, HH | 1 |
Vinh, PN | 1 |
Beaumier, A | 1 |
Rush, JE | 1 |
Yang, VK | 1 |
Freeman, LM | 1 |
Yata, M | 1 |
Kooistra, HS | 1 |
Beijerink, NJ | 1 |
Bhargava, R | 1 |
Cowell, R | 1 |
Peddle, GD | 1 |
Singletary, GE | 1 |
Reynolds, CA | 1 |
Trafny, DJ | 1 |
Machen, MC | 1 |
Oyama, MA | 1 |
de Madron, E | 1 |
King, JN | 1 |
Strehlau, G | 1 |
White, RV | 1 |
Wolf, J | 1 |
Gerlach, N | 1 |
Weber, K | 1 |
Klima, A | 1 |
Wess, G | 1 |
Kula, S | 1 |
Saygili, A | 1 |
Tunaoğlu, FS | 1 |
Olguntürk, R | 1 |
Prasad, GV | 1 |
Vincent, L | 1 |
Hamilton, R | 1 |
Lim, K | 1 |
Gupta, N | 1 |
Dalmia, S | 1 |
Deka, D | 1 |
Mittal, S | 1 |
Krahwinkel, W | 1 |
Kober, R | 1 |
Horstkotte, D | 1 |
Borchard, F | 1 |
Winter, J | 1 |
Strauer, BE | 1 |
Königshausen, T | 1 |
Casazza, F | 1 |
Faorista, F | 1 |
Donatelli, F | 1 |
Grossi, A | 1 |
Häggström, J | 1 |
Hansson, K | 1 |
Karlberg, BE | 1 |
Kvart, C | 1 |
Madej, A | 1 |
Olsson, K | 1 |
Biller, B | 1 |
Hörauf, A | 1 |
Kraft, W | 1 |
Ettinger, SJ | 1 |
Benitz, AM | 1 |
Ericsson, GF | 1 |
Cifelli, S | 1 |
Jernigan, AD | 1 |
Longhofer, SL | 1 |
Trimboli, W | 1 |
Hanson, PD | 1 |
Gradinac, S | 1 |
Jovanović, I | 1 |
Dukić, M | 1 |
Hercog, D | 1 |
Jovović, L | 1 |
Kokai, G | 1 |
Stajević, M | 1 |
Simeunović, S | 1 |
Rishniw, M | 1 |
Carmel, BP | 1 |
Atwell, RB | 1 |
McLintic, AJ | 1 |
Metcalfe, MJ | 1 |
Ingram, KS | 1 |
Dougall, JR | 1 |
Wehling, M | 1 |
Zimmermann, J | 1 |
Weil, J | 1 |
Gerzer, R | 1 |
Theisen, K | 1 |
Stevenson, LW | 1 |
Brunken, RC | 1 |
Belil, D | 1 |
Grover-McKay, M | 1 |
Schwaiger, M | 1 |
Schelbert, HR | 1 |
Tillisch, JH | 1 |
Nikolić, VH | 1 |
Omcikus, MP | 1 |
Mihatov, S | 1 |
Rudar, M | 1 |
Vukosavić, D | 1 |
Petrać, D | 1 |
Ronan, JA | 1 |
Hanrath, P | 1 |
Bleifeld, W | 1 |
Mathey, D | 1 |
Merx, W | 1 |
Szám, I | 1 |
Sólyom, I | 1 |
Fischer, J | 1 |
Levi, GF | 1 |
Proto, C | 1 |
1 review available for furosemide and Mitral Valve Insufficiency
Article | Year |
---|---|
Acute poststreptococcal glomerulonephritis and acute rheumatic fever in the same patient: a case report and review of the literature.
Topics: Acute Disease; Adolescent; Child; Diagnosis, Differential; Echocardiography, Doppler; Female; Furose | 2003 |
5 trials available for furosemide and Mitral Valve Insufficiency
Article | Year |
---|---|
Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease.
Topics: Animals; Cross-Over Studies; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Mitral Valve | 2012 |
[Treatment of mitral valve insufficiency in dogs with the ACE inhibitor enalapril. A clinical progress study].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diuretics; Dog Diseases; Dogs; Drug Therapy, Comb | 1998 |
Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Deat | 1998 |
[Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure].
Topics: Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Dilated; Coronary Disease; Cyclic GMP; De | 1990 |
[Biometric assay of the saluretic synergism of clopamide and furosemide].
Topics: Adult; Aged; Amides; Aortic Valve Insufficiency; Biometry; Clinical Trials as Topic; Clopamide; Diur | 1969 |
27 other studies available for furosemide and Mitral Valve Insufficiency
Article | Year |
---|---|
Cardiorenal Syndrome Triggered by Slowly Progressive Drugs Toxicity-Induced Renal Failure along with Minimal Mitral Disease: A Case Report.
Topics: Aged, 80 and over; Cardio-Renal Syndrome; Female; Furosemide; Heart Failure; Humans; Mitral Valve; M | 2022 |
Mineralocorticoid Receptor Antagonists Mitigate Mitral Regurgitation-Induced Myocardial Dysfunction.
Topics: Animals; Fibrosis; Furosemide; Heart Failure; Mineralocorticoid Receptor Antagonists; Mitral Valve I | 2022 |
Resolution of congestive heart failure and reverse remodeling in two Chihuahuas with flail mitral valve leaflets.
Topics: Animals; Dog Diseases; Dogs; Furosemide; Heart Failure; Heart Valve Diseases; Male; Mitral Valve; Mi | 2023 |
What is causing this patient's recurrent cough and dyspnea?
Topics: Adrenergic beta-Antagonists; Adult; Bundle-Branch Block; Cough; Diagnosis, Differential; Dyspnea; Ec | 2020 |
Multiple retrospective analysis of survival and evaluation of cardiac death predictors in a population of dogs affected by degenerative mitral valve disease in ACVIM class C treated with different therapeutic protocols.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cohort Studies; Death; Dog Diseases; Dogs; Female | 2021 |
Progression of Tricuspid Regurgitation after Mitral Valve Replacement for Rheumatic Heart Disease.
Topics: Adult; Chi-Square Distribution; Disease Progression; Echocardiography, Doppler; Female; Furosemide; | 2017 |
Clinical findings and survival time in dogs with advanced heart failure.
Topics: Animals; Cardiotonic Agents; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Male; Mitral Val | 2018 |
What Is Your Diagnosis?
Topics: Animals; Atherosclerosis; Bird Diseases; Cardiotonic Agents; Diagnosis, Differential; Diuretics; Ech | 2018 |
Cardiorenal and endocrine effects of synthetic canine BNP1-32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease.
Topics: Aldosterone; Animals; Cross-Over Studies; Dog Diseases; Dogs; Furosemide; Heart Failure; Heart Valve | 2019 |
Unilateral pulmonary oedema.
Topics: Acute Coronary Syndrome; Administration, Intravenous; Aged; Angioplasty; Diuretics; Dyspnea; Furosem | 2019 |
Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Cardiotonic Agents; Death, Sudden, | 2011 |
Lowered N-terminal pro-B-type natriuretic peptide levels in response to treatment predict survival in dogs with symptomatic mitral valve disease.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Male; Mitral Valve Insuff | 2012 |
Minimal change disease in association with fire coral (Millepora species) exposure.
Topics: Acute Kidney Injury; Animals; Anthozoa; Barbados; Bites and Stings; Combined Modality Therapy; Divin | 2006 |
Successful maternal and fetal outcome in a pregnancy with type V Takayasu's aortoarteritis.
Topics: Adult; Antihypertensive Agents; Arterial Occlusive Diseases; Calcium Channel Blockers; Diuretics; Fe | 2008 |
[Acute mitral insufficiency in osteogenesis imperfecta].
Topics: Aortic Valve; Captopril; Cardiac Catheterization; Drug Therapy, Combination; Dyspnea; Echocardiograp | 1994 |
[Acute myocardial infarction in bacterial endocarditis].
Topics: Aortic Valve; Aortic Valve Insufficiency; Cardiotonic Agents; Digoxin; Diuretics; Echocardiography, | 1996 |
Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Dog Dis | 1996 |
Partial left ventriculectomy in a two-year-old girl with dilated cardiomyopathy.
Topics: Antihypertensive Agents; Captopril; Cardiomyopathy, Dilated; Cardiotonic Agents; Child, Preschool; D | 1999 |
Atrioventricular valvular insufficiency and congestive heart failure in a carpet python.
Topics: Animals; Boidae; Diuretics; Echocardiography, Doppler, Color; Electrocardiography; Fatal Outcome; Fu | 1999 |
The use of alpha blockade in the treatment of congestive heart failure associated with dirofilariasis and mitral valvular incompetence.
Topics: Animals; Digoxin; Dirofilariasis; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Male; Mitra | 1979 |
Acute mitral regurgitation: physiological and pharmacological considerations in the management of a critically ill patient.
Topics: Acute Disease; Combined Modality Therapy; Critical Illness; Dopamine; Female; Furosemide; Humans; In | 1992 |
Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure.
Topics: Bumetanide; Diuretics; Exercise; Female; Ferricyanides; Furosemide; Heart; Heart Failure; Humans; Ma | 1990 |
Daily administration of furosemide in dilated cardiomyopathy--yes or no?
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Cardiac Volume; Cardiomyopathy, Dilated; Drug Administr | 1990 |
Managing pulmonary edema.
Topics: Antihypertensive Agents; Bloodletting; Bronchodilator Agents; Digitalis; Digoxin; Furosemide; Heart | 1973 |
[Acute myocardial infarction (author's transl)].
Topics: Acute Disease; Adult; Aged; Blood Pressure; Cardiac Catheterization; Digoxin; Female; Furosemide; Ge | 1974 |
Heart failure. II.
Topics: Aged; Aortic Valve Insufficiency; Digitoxin; Digoxin; Ethacrynic Acid; Female; Furosemide; Heart Fai | 1971 |
[Hypotensive effect of furosemide on the pulmonary circulation of mitral patients. (Preliminary note)].
Topics: Adult; Diuretics; Female; Furosemide; Humans; Hypertension, Pulmonary; Male; Middle Aged; Mitral Val | 1966 |